Atricure Inc

NASDAQ:ATRC   11:37:11 AM EDT
65.00
-0.83 (-1.26%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.96B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$56.07 Million
Adjusted EPS-$0.39
See more estimates
10-Day MA$65.08
50-Day MA$63.80
200-Day MA$49.47
See more pivots

AtriCure, Inc. Stock, NASDAQ:ATRC

7555 Innovation Way, Mason, Ohio 45069
United States of America
Phone: +1.513.755.4100
Number of Employees: 730

Description

AtriCure, Inc. engages development, manufacture and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio Frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, Other International, and Total International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in West Chester, OH.